The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum

Journal of Dermatological Treatment

Volumn 12, Issue 1, 2001, Pages 19-22

  Hagman, J H ^a   Carrozzo, A M ^a   Campione, E ^a   Romanelli, P ^b   Chimenti, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Immunoglobulin; Pyoderma gangrenosum

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; PARACETAMOL;

AGED; ARTICLE; CASE REPORT; CHILL; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG TOLERANCE; FEVER; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LEG ULCER; MALE; PAIN; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SEPTICEMIA; TREATMENT OUTCOME; WOUND HEALING;

AGED; AGED, 80 AND OVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEG ULCER; MALE; PYODERMA GANGRENOSUM;

EID: 0035028598     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466301750163527     Document Type: Article

References (28)

1. Pyoderma gangrenosum: Classification and management
2. Neutrophilic dermatoses: Pyoderma gangrenosum and Sweet's syndrome
3. Neutrophilic vascular reactions
4. Pyoderma gangrenosum: A review
5. Pyoderma gangrenosum
6. Pyoderma gangrenosum in inflammatory bowel disease
7. Subcutaneous abscesses in a patient with ulcerative colitis
8. Pyoderma gangrenosum in an HIV-infected patient
9. Pyoderma gangrenosum in infants and children
10. Pyoderma gangrenosum in infancy: The youngest reported patient
11. Treatment of pyoderma gangrenosum
12. Pyoderma gangrenosum: A case report of 44 cases with follow-up
13. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum
14. Nicotine for pyoderma gangrenosum
15. Efficacy of human intravenous immunoglobuline in pyoderma gangrenosum
16. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin
17. Manipulating the immune system with immune globulin
18. Mechanism of action of intravenous immune globulin in immune mediated diseases
19. Modulation of complement-mediated immune damage by intravenous immune globulin
20. Intravenous immune globulin affects cytochine production in T lymphocytes and monocytes/macrophages
21. Established and new therapeutic approaches in dermatomyositis, polimyositis and overlapping syndromes
22. Dermatological uses of high-dose intravenous immunoglobulin
23. High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris
24. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: Experience in six patients
25. Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins
26. Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS
27. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
28. High-dose gammaglobulin treatment for atopic dermatitis